<DOC>
	<DOCNO>NCT00911027</DOCNO>
	<brief_summary>This phase III European multicenter , open label , prospective study assess diagnostic accuracy use SonoVue contrast agent guide prostate biopsy comparison current practice ultrasound guide systematic biopsy . The trial involve 15-20 European Centers .</brief_summary>
	<brief_title>SonoVue Guided Prostate Biopsy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Male patient , age ≥ 40 year old Optimization part : Diagnosis prostate cancer Main part : Suspected prostate cancer schedule first biopsy tPSA ≤ 10 ng/mL OR already submit one systematic bioptic procedure negative result currently follow procedure due persistent indication . Written Informed Consent willing comply protocol requirement Documented acute prostatitis urinary tract infection Known allergy sulphur hexafluoride micro bubble Any clinically unstable cardiac condition within 7 day prior SonoVue® administration : evolve ongoing myocardial infarction typical angina rest within previous 7 day significant worsening cardiac symptom within previous 7 day recent coronary artery intervention factor suggest clinical instability ( e.g. , recent deterioration ECG , laboratory clinical finding ) acute cardiac failure , class III/IV cardiac failure severe cardiac rhythm disorder righttoleft shunt Severe pulmonary hypertension uncontrolled systemic hypertension respiratory distress syndrome Bioptic procedure within 30 day admission study ( exclusion criterion main part study ) Determined Investigator patient clinically unsuitable study Participation concurrent clinical trial another trial within past 30 day Repeated participation trial ( patient enrol twice present study )</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Prostate</keyword>
	<keyword>Cancer</keyword>
	<keyword>Biopsy</keyword>
	<keyword>Guided</keyword>
	<keyword>Contrast</keyword>
	<keyword>Enhanced</keyword>
	<keyword>SonoVue</keyword>
	<keyword>Suspicion prostate cancer</keyword>
</DOC>